Compare AVXL & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVXL | YORW |
|---|---|---|
| Founded | 2004 | 1816 |
| Country | United States | United States |
| Employees | N/A | 104 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.9M | 472.0M |
| IPO Year | 2013 | 1994 |
| Metric | AVXL | YORW |
|---|---|---|
| Price | $2.82 | $30.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 126.0K |
| Earning Date | 05-12-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 2.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | N/A | ★ $77,488,000.00 |
| Revenue This Year | N/A | $11.78 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | ★ N/A | $21.92 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $2.61 | $29.68 |
| 52 Week High | $13.99 | $36.48 |
| Indicator | AVXL | YORW |
|---|---|---|
| Relative Strength Index (RSI) | 26.55 | 38.67 |
| Support Level | N/A | $30.02 |
| Resistance Level | $4.98 | $32.98 |
| Average True Range (ATR) | 0.28 | 0.68 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 8.85 | 33.80 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.